Loading…
Codex Genetics is a precision genomics company that produces a BRCA panel report for hereditary cancer risk assessment. The report provides clear, stratified risk information and aligns with NCCN guidelines, with a turnaround time under 21 days.
AI named Codex Genetics from January 2026 to February 2026.
